Award
NIH Reporter #5R01CA278100-04
Evaluating unique aspects of quiescent ovarian cancer cell biology for therapeutic targets
Recipient
Not specified
Award Amount
$435,361.00
Ceiling
$435,361.00
Awarded
June 23, 2026
Identifier
5R01CA278100-04
NIH grant awarded by the National Cancer Institute to study quiescent ovarian cancer cell biology for therapeutic target identification and treatment evaluation.
Description
This is a NIH grant project focused on studying the biology of quiescent ovarian cancer cells to identify therapeutic targets and test novel treatment combinations. The project involves multiple approaches including transcriptional signature analysis, pathway characterization, and in vivo evaluation of therapeutic strategies.